The technology will help redefine how global health challenges - from superbugs to infectious diseases, and cancer are conquered.
|
[21-November-2017] |
AUSTIN, Texas, Nov. 21, 2017 /PRNewswire/ -- Nano Global, an Austin-based molecular data company, today announced that it is developing a chip using intellectual property (IP) from Arm, the world’s leading semiconductor IP company. The technology will help redefine how global health challenges - from superbugs to infectious diseases, and cancer are conquered. The pioneering system-on-chip (SoC) will yield highly-secure molecular data that can be used in the recognition and analysis of health threats caused by pathogens and other living organisms. Combined with the company’s scientific technology platform, the chip leverages advances in nanotechnology[1], optics[2], artificial intelligence (AI)[3], blockchain authentication[4], and edge computing[5] to access and analyze molecular-level data in real time. “In partnership with Arm, we’re tackling the vast frontier of molecular data to unlock the unlimited potential of this universe,” said Steve Papermaster, Chairman and CEO of Nano Global. “The data our technology can acquire and process will enable us to create a safer and healthier world.” “We believe the technology Nano Global is delivering will be an important step forward in the collective pursuit of care that improves lives through the application of technology,” said Rene Haas, executive vice president and president of IPG, Arm. “By collaborating with Nano Global, Arm is taking an active role in developing and deploying the technologies that will move us one step closer to solving complex health challenges.” Additionally, Nano Global will be partnering with several leading institutions, including Baylor College of Medicine and National University of Singapore, on broad research initiatives in clinical, laboratory, and population health environments to accelerate data collection, analysis, and product development. The initial development of the chip is in process with first delivery expected by 2020. The company is already adding new partners to their platform. For more information visit: www.nanoglobal.com. Statistics on antimicrobial resistance / cancer
All statistics are taken from reports compiled by the World Health Organisation (WHO), the US Centers for Disease Control and Prevention (CDC) and the UK government-funded Review on Antimicrobial Resistance (AMR). Technology references: About Nano Global Nano™ is a trademark of Nano Global - all other trademarks are of their respective owners.
View original content with multimedia:http://www.prnewswire.com/news-releases/nano-global-arm-collaborate-on-artificial-intelligence-chip-to-drive-health-revolution-by-capturing-and-analyzing-molecular-data-in-real-time-300559508.html SOURCE Nano Global |